EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dexmedetomidine Blocks the ERK Pathway by Inhibiting MAP3K8 to Achieve a Protective Effect in Lung Ischemia/Reperfusion Injury

Chun-Huan Hu, Ru Qian, Yong-Bo Wang, Lian-Di Li, Chun-Xing Miao iD

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Chun-Huan Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China. Hauptthemen laut MEDLINE: Dexmedetomidine, Reperfusion Injury, MAP Kinase Signaling System, Lung. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Research Business Expenses for Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung ischemia/reperfusion injury (LIRI) is a primary contributor to morbidity and mortality following lung transplantation. Dexmedetomidine (DEX) protects the lungs from I/R injury, but the underlying mechanisms remain uncertain. This paper examined the protective effect of DEX in LIRI and elucidated the potential regulation involved. LIRI was induced in mice, followed by the detection of pulmonary arterial pressure, lung compliance, pathological changes, pulmonary vascular permeability, oxidative stress, inflammation, and apoptosis. Mice were infected with overexpression (OE)‐mitogen‐activated protein kinase kinase kinase 8 (MAP3K8) adenovirus and treated with DEX. MAP3K8 expression was examined in mouse lung tissue and pulmonary microvascular endothelial cells (PMVECs). Cells were infected using OE‐MAP3K8 lentivirus and treated with DEX, followed by detection of cell viability and apoptosis, VE‐cadherin and α‐E‐catenin, and pro‐inflammatory factors. Rescue experiments were performed by MAP3K8 overexpression and combined extracellular signal‐regulated protein kinase (ERK) pathway blocker, PD98059. The results demonstrated that DEX protected mice from LIRI. DEX inhibited MAP3K8 expression. MAP3K8 overexpression increased ERK1/2 phosphorylation and activated the ERK pathway. Upregulation of MAP3K8 impaired the protective effect of DEX in vivo and in vitro, which was reversed by the ERK inhibitor PD98059. Overall, DEX achieved its protective effect against LIRI by inhibiting the MAP3K8‐ERK axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineReperfusion InjuryMAP Kinase Signaling SystemLungMAP Kinase Kinase KinasesAnimalsMiceApoptosisMaleFlavonoidsMice, Inbred C57BLEndothelial CellsOxidative StressCadherins

Stichwörter der Autor:innen

ERK pathwayMAP3K8dexmedetomidineinflammationlung ischemia/reperfusion injury

Substanzen

DexmedetomidineMAP Kinase Kinase Kinases2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneFlavonoidsCadherins

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China.
  • Department of Critical Medicine, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China.
  • Department of Respiratory Medicine, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China.
  • Department of Chest Surgery, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China.

ORCID-Profile: Chun-Xing Miao

Förderung

  • Basic Research Business Expenses for Scientific Research Project

Zitieren

APA

Hu, C. H., Qian, R., Wang, Y. B., Li, L. D., & Miao, C. X. (2025). Dexmedetomidine Blocks the ERK Pathway by Inhibiting MAP3K8 to Achieve a Protective Effect in Lung Ischemia/Reperfusion Injury. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70045

Vancouver

Hu CH, Qian R, Wang YB, Li LD, Miao CX. Dexmedetomidine Blocks the ERK Pathway by Inhibiting MAP3K8 to Achieve a Protective Effect in Lung Ischemia/Reperfusion Injury. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70045

BibTeX
@article{Hu2025,
  author = {Hu, Chun-Huan and Qian, Ru and Wang, Yong-Bo and Li, Lian-Di and Miao, Chun-Xing},
  title = {Dexmedetomidine Blocks the ERK Pathway by Inhibiting MAP3K8 to Achieve a Protective Effect in Lung Ischemia/Reperfusion Injury},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70045}
}
Kostenlos starten →